Over the course of our fifteen year history, we have selectively engaged external partners as a fundamental component of our business model. With our first groundings tied to leading academic institutions, we continually look to partner with the best in academia as well as other companies that may share our commitment to innovation and our passion to advance understandings of cytoskeletal pharmacology with a shared goal to bring our drug candidates forward and closer to ultimately benefiting patients in need.

Cytokinetics continues to execute against a business vision that was initially established at the company’s inception and is equally valid today. We have maintained discipline and focus to our key business objectives. Our vision has always been to develop a sustainable, durable, fully integrated biopharmaceutical company by leveraging a biology-centric platform focused towards the treatment of diseases for patients with significant clinical unmet needs. Ensuring we maintain a viable business requires that we selectively transact key collaborations and maintain ready access to a lower cost of capital. Our long range and shorter term planning activities continually inform key steps we are taking along the way and also distill for us the suitable contingencies and decision pivot points intended to keep us on solid footing as we push forward. In time, we may also execute on our carefully-constructed commercial plans that would then deliver on the next-level business strategies.

To learn more, please visit our Strategies and Partnerships pages.